Parkside Investments’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$265K Hold
3,391
0.03% 87
2026
Q1
$294K Hold
3,391
0.04% 91
2025
Q4
$326K Hold
3,391
0.04% 85
2025
Q3
$323K Hold
3,391
0.04% 86
2025
Q2
$296K Sell
3,391
-3
-0.1% -$254 0.04% 83
2025
Q1
$305K Hold
3,394
0.04% 85
2024
Q4
$271K Sell
3,394
-300
-8% -$26K 0.04% 86
2024
Q3
$333K Hold
3,694
0.05% 83
2024
Q2
$291K Sell
3,694
-1,000
-21% -$82K 0.05% 84
2024
Q1
$409K Hold
4,694
0.06% 79
2023
Q4
$387K Hold
4,694
0.07% 87
2023
Q3
$368K Hold
4,694
0.07% 78
2023
Q2
$414K Hold
4,694
0.08% 74
2023
Q1
$378K Buy
+4,694
New +$383K 0.07% 81
2022
Q4
Sell
-9,003
Closed -$726K 94
2022
Q3
$726K Hold
9,003
0.16% 69
2022
Q2
$808K Buy
9,003
+3,000
+50% +$304K 0.17% 65
2022
Q1
$666K Buy
+6,003
New +$634K 0.13% 70
2018
Q1
Sell
-2,500
Closed -$202K 95
2017
Q4
$202K Buy
+2,500
New +$200K 0.1% 94

Other funds holding MDT

Parkside Investments's MDT Position: Q2 2026 in Review

Parkside Investments held its Medtronic (MDT) position steady in Q2 2026 at 3,391 shares worth $265K. The position accounts for 0.03% of the portfolio, ranked #87.

Parkside Investments first reported a position in MDT in Q4 2017 and has held it in 18 quarters since. The position peaked at $808K in Q2 2022. 729 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Parkside Investments held 3,391 shares of Medtronic worth $265K as of Q2 2026.
  • Parkside Investments left its Medtronic share count unchanged in Q2 2026.
  • Medtronic made up 0.03% of Parkside Investments's portfolio in Q2 2026, its #87 holding.
  • Parkside Investments first reported a position in Medtronic in Q4 2017 and has held it in 18 quarters since.
  • Parkside Investments's Medtronic position peaked at $808K in Q2 2022.
  • 729 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Parkside Investments's 13F filing for Q2 2026, filed 13 Jul 2026.